Omnicell Stock Performance
| OMCL Stock | USD 27.49 0.61 2.27% |
The company holds a Beta of 1.61, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Omnicell will likely underperform. At this point, Omnicell has a negative expected return of -0.0857%. Please make sure to check Omnicell's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Omnicell performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Omnicell has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Omnicell is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return (3.90) | Five Day Return (2.33) | Year To Date Return (39.35) | Ten Year Return (31.66) | All Time Return 206.85 |
1 | Omnicell Price Target Slashed Amid Tariff Concerns OMCL Stock News | 05/07/2025 |
2 | It Looks Like Omnicell, Inc.s CEO May Expect Their Salary To Be Put Under The Microscope | 05/14/2025 |
3 | Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program | 05/22/2025 |
4 | Acquisition by Seim Robin Gene of 6828 shares of Omnicell subject to Rule 16b-3 | 05/30/2025 |
5 | Patient Transfer Robot Market to Reach 2.9 Billion by 2034, Driven by 9.2 percent CAGR Exactitude Consultancy | 06/02/2025 |
6 | Omnicell Up 27 percent Since Last Earnings Report Can It Continue | 06/05/2025 |
7 | Do Options Traders Know Something About Omnicell Stock We Dont | 06/13/2025 |
8 | Zacks Research Issues Negative Outlook for Omnicell Earnings | 06/25/2025 |
9 | Omnicell, Inc. dropped from Russell 2000 Value-Defensive Index - MarketScreener | 06/30/2025 |
10 | Pharmacy Automation Market Outlook Report 2025, with Key Vendor Profiles for ARxIUM, Baxter, BD, Capsa Healthcare, Cencora, McKesson, and Omnicell - ResearchAnd... | 07/09/2025 |
11 | Acquisition by Ghoshal Kaushik of 5717 shares of Omnicell subject to Rule 16b-3 | 07/11/2025 |
12 | Omnicell Faces Target Price Adjustment Amid Revenue Uncertainty OMCL Stock News | 07/14/2025 |
13 | Omnicell Could Be Struggling To Allocate Capital | 07/17/2025 |
| Begin Period Cash Flow | 501 M | |
| Total Cashflows From Investing Activities | -52.8 M |
Omnicell Relative Risk vs. Return Landscape
If you would invest 2,992 in Omnicell on April 22, 2025 and sell it today you would lose (243.00) from holding Omnicell or give up 8.12% of portfolio value over 90 days. Omnicell is currently does not generate positive expected returns and assumes 3.0726% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Omnicell, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Omnicell Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omnicell's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Omnicell, and traders can use it to determine the average amount a Omnicell's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0279
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OMCL |
Estimated Market Risk
| 3.07 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Omnicell is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Omnicell by adding Omnicell to a well-diversified portfolio.
Omnicell Fundamentals Growth
Omnicell Stock prices reflect investors' perceptions of the future prospects and financial health of Omnicell, and Omnicell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Omnicell Stock performance.
| Return On Equity | 0.0173 | ||||
| Return On Asset | 0.0035 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 1.25 B | ||||
| Shares Outstanding | 46.84 M | ||||
| Price To Earning | 64.95 X | ||||
| Price To Book | 1.00 X | ||||
| Price To Sales | 1.11 X | ||||
| Revenue | 1.11 B | ||||
| Gross Profit | 491.12 M | ||||
| EBITDA | 90.09 M | ||||
| Net Income | 12.53 M | ||||
| Cash And Equivalents | 244.95 M | ||||
| Cash Per Share | 5.53 X | ||||
| Total Debt | 382.55 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.11 X | ||||
| Book Value Per Share | 26.84 X | ||||
| Cash Flow From Operations | 187.72 M | ||||
| Earnings Per Share | 0.46 X | ||||
| Market Capitalization | 1.26 B | ||||
| Total Asset | 2.12 B | ||||
| Retained Earnings | 382.89 M | ||||
| Working Capital | 219.81 M | ||||
| Current Asset | 50.15 M | ||||
| Current Liabilities | 50.17 M | ||||
About Omnicell Performance
By examining Omnicell's fundamental ratios, stakeholders can obtain critical insights into Omnicell's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Omnicell is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 50.47 | 84.02 | |
| Return On Tangible Assets | 0.01 | 0.02 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Omnicell performance evaluation
Checking the ongoing alerts about Omnicell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Omnicell help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Omnicell generated a negative expected return over the last 90 days | |
| Omnicell has high historical volatility and very poor performance | |
| Omnicell has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Omnicell Could Be Struggling To Allocate Capital |
- Analyzing Omnicell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Omnicell's stock is overvalued or undervalued compared to its peers.
- Examining Omnicell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Omnicell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Omnicell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Omnicell's stock. These opinions can provide insight into Omnicell's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.558 | Earnings Share 0.46 | Revenue Per Share | Quarterly Revenue Growth 0.096 | Return On Assets |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.